Abiopharma

News list

Heyman Richard A. 🔴 sold 6.7K shares of Oric Pharmaceuticals, Inc. (ORIC) at $12.00 Transaction Date: Jan 16, 2026 | Filing ID: 000006

Full text

News bot Jan. 29, 2026, 2:21 p.m.
🔍 Heyman Richard A. (Executive)

Company: Oric Pharmaceuticals, Inc. (ORIC)

Report Date: 2026-01-16
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,700
Detailed Transactions and Holdings:
- Sold 3,500 shares of Common Stock at $12.0046 per share (Direct)
  Date: 2026-01-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 41,800.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Sold 3,200 shares of Common Stock at $12.0046 per share (Direct)
  Date: 2026-01-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 213,072.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.
- F2: Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.